Monday Conrad Duke of Windsor Park South Basildon East Foyer Jade February 13, 2012 4th Floor 3rd Floor 7:00 – 8:00am Networking Breakfast: Grand Ballroom 8:00 – 8:45am Fireside Chat with Moncef Slaoui, PhD, Chairman, Research & Development, GlaxoSmithKline plc (Jade) Provectus Sucampo Zalicus Palatin Technologies Ligand Pharmaceuticals 8:30 – 8:55am Pharmaceuticals Pharmaceuticals Phylogica Theratechnologies Corporate Strategy: Titan Pharmaceuticals Celsion Corporation ARIAD Pharmaceuticals 9:00 – 9:25am (Australia) (Canada) Walking the Line—Finding a Happy ACADIA Medium Between Management OncoSec Medical XOMA Synta Pharmaceuticals NPS Pharmaceuticals 9:30 – 9:55am Pharmaceuticals and Shareholders Cyclacel GENFIT Compugen PolyMedix Curis 10:00 – 10:25am Pharmaceuticals (France) (Israel) Oncology: Idera Pharmaceuticals Advaxis JDRF Cerus Corporation Chelsea Therapeutics 10:30 – 10:55am Secrets of Oncology Success– Antisense Therapeutics SciClone Lessons &Trends in Phase II 11:00 – 11:25am Unigene Laboratories Onconova Therapeutics Inovio Pharmaceuticals (Australia) Pharmaceuticals Clinical Trial Outcomes Navidea Azanta A/S Medicago Opexa Therapeutics Neurocrine Biosciences 11:30 – 11:55am Biopharmaceuticals (Denmark) (Canada) 12:00 – 12:55pm Opening Plenary Session (Jade) (Box Lunch) Picks and Pans - The Buy-side View For 2012 ImmunoCellular Syndax Cytokinetics NanoViricides PDL BioPharma 1:00 – 1:25pm Therapeutics Pharmaceuticals Resverlogix Corp. Novozymes A/S OXiGENE Ambit Biosciences Orexigen Therapeutics Neurology: 1:30 – 1:55pm (Canada) (Denmark) Alz Well That Ends Well— e-Therapeutics plc Zealand Pharma A/S WaferGen Biosystems Verastem: VSTM Repligen Corporation Settling the Beta-Amyloid Debate 2:00 – 2:25pm (United Kingdom) (Denmark) KaloBios Biotie Therapies Corp. Alkermes plc Aradigm Corporation Galena Biopharma 2:30 – 2:55pm Pharmaceuticals (Finland) (Ireland) QRxPharma Limited EpiCept Corporation Neuralstem KineMed Infinity Pharmaceuticals Business: 3:00 – 3:25pm (Australia) Healthy Alternatives: Financing Children’s Tumor Synergy Agenus Ikaria Trius Therapeutics Mechanisms that Sustain Companies 3:30 – 3:55pm Foundation Pharmaceuticals OncoMed Tranzyme Novelos Therapeutics Novavax Rigel Pharmaceuticals 4:00 – 4:25pm Pharmaceuticals Jennerex DiaMedica MethylGene Ventrus Biosciences VirtualScopics 4:30 – 4:55pm Biotherapeutics (Canada) (Canada) Legend - Purple: Private Companies 5:00 – 6:30pm BIO CEO Reception (Empire Room) - Blue: Patient Advocacy
Waldorf=Astoria Hotel As of 2/14/2012: Schedule subject to change. Please refer to our website for up-to-date information. www.bio.org/bioceo New York, NY - 1 - [email protected]
Tuesday Conrad Duke of Windsor Park South Basildon East Foyer Jade February 14, 2012 4th Floor 3rd Floor 7:00 – 8:00am Networking Breakfast: Grand Ballroom 8:00 – 8:45am Fireside Chat with Mikael Dolsten, MD, PhD, Head of Worldwide Research, Pfizer, Inc. (Jade) OncoGenex TONIX Peregrine Delcath Systems Exelixis 8:30 – 8:55am Pharmaceuticals Pharmaceuticals Pharmaceuticals Transcept Addex Pharmaceuticals Keryx BioMarin Athersys Corporate Development: 9:00 – 9:25am Pharmaceuticals (Switzerland) Biopharmaceuticals Pharmaceutical Countdown to Launch – Rett Syndrome Aegerion NeoStem AVI BioPharma ZIOPHARM Oncology Getting It Right the First Time 9:30 – 9:55am Research Trust Pharmaceuticals NovaBay BioLineRx Lexicon Sunesis Pharmaceuticals Idenix Pharmaceuticals 10:00 – 10:25am Pharmaceuticals (Israel) Pharmaceuticals Biotron Limited BioSante Achillion Galectin Therapeutics DURECT Corporation Diagnostics: 10:30 – 10:55am (Australia) Pharmaceuticals Pharmaceuticals Drugs Need Friends Too – Companion ADVENTRX Agennix AG GenVec StemCells Arena Pharmaceuticals Diagnostics & Drug Development 11:00 – 11:25am Pharmaceuticals (Germany) ALS Therapy Human Tengion CytRx Corporation Astex Pharmaceuticals 11:30 – 11:55am Development Institute Genome Sciences 12:00 – 12:55pm Luncheon Plenary (Jade) (Box Lunch) Value Drivers Under the Influence: How Licensing and Key Events Affect Valuation Selvita S.A. 1:00 – 1:25pm Repros Therapeutics Oragenics TBD Acorda Therapeutics (Poland) 1:15 – 2:10pm Cardiology: Telik Horizon Pharma Interleukin Genetics Geron Corporation Targacept 1:30 – 1:55pm Shot to the Heart—The Race to Conquer Allon Therapeutics Neovacs SA Bavarian Nordic A/S Dyslipidemia/Hypercholesterolemia 2:00 – 2:25pm pSivida Corp. MannKind Corporation (Canada) (France) (Denmark) Michael J. Fox Immunovaccine Fireside Chat: John Milligan, PhD, Omeros Corporation DUSA Pharmaceuticals Oncothyreon 2:30 – 2:55pm Foundation (Canada) President & COO, Gilead Veloxis Pharmaceuticals Cleveland BioLabs NuPathe Affymax ImmunoGen 3:00 – 3:25pm (Denmark) Æterna Zentaris Spectrum Anavex Life Sciences Genta Incorporated TBD 3:30 – 3:55pm (Canada) Pharmaceuticals Legend -Gray: Patient Advocacy 4:00 – 5:00pm Closing Plenary Session: Inside the FDA (Jade) 5:00 – 6:00pm Closing Happy Hour (Silver Corridor)
Waldorf=Astoria Hotel As of 2/14/2012: Schedule subject to change. Please refer to our website for up-to-date information. www.bio.org/bioceo New York, NY - 2 - [email protected]